Published in Medical Verdicts and Law Weekly, March 27th, 2008
"There is a broad community of patient advocates, researchers, policy makers and companies who are all passionate about supporting a change in SBIR eligibility to allow companies...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Verdicts and Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.